AI-driven dermatology platform Cureskin has netted $20 million in a Series B funding round led by HealthQuad. The round was also participated by JSW Ventures, Khosla Ventures, and Sharrp Ventures.
"These funds will help further enhance our AI capabilities, accelerate our growth, and expand solution offerings," said co-founder and CEO Guna Kakulapati in a statement.
Cureskin previously raised $5...
